手机咨询更便捷
扫码立即和HR沟通
任职要求- Master degree in the major of Clinical medical, pharmaceutical, biomedical engineering or other relative majors;
- Good English and Chinese both in oral and written, able to use as working language;
- Strong execution and teamwork skills, Excellent communication and negotiation skills;
- Experience in foreign enterprises, hospitals, government departments and industry associations in the pharmaceutical field is preferred;
- Familiar with new drug clinical trials, registration regulations, GCP regulations is preferred.
- 临床医学、药学、生物医学工程等相关专业硕士研究生学历;
- 良好的写作、中英文语言表达能力;
- 较强的执行力和团队合作能力,优秀的沟通和谈判能力;
- 具有在跨国医药外企、医疗机构、国家部委机关事业单位以及医药相关行业协会(学会)等工作经验者优先,熟悉新药临床试验与注册法规、GCP法规、具有与国家政府部门对接经历者优先。
The R&D (Research and Development) team of Dizal Pharma was AstraZeneca Asia and Emerging Market Research Center. As one of AstraZeneca’s first four R&D centers across the world, it dedicated to analyze the potential scientific mechanism of those most common diseases in Asia and fulfill the particular medical needs of Asian patients. It was one of the few R&D centers established by transnational pharmacy enterprises in China which had the ability to actually research, develop and produce micro-molecular new drugs, the ability to develop produce new drugs independently and completely, and the first-class medical platform in the world.
迪哲医药,于2017年10月独立运营,是一家研发驱动型生物医药企业,致力于全球创新药物(First-in-class/ Best-in-class)探索、研发以及商业化。
迪哲医药的前身为阿斯利康亚洲及新兴市场创新研发中心,设立于中国上海,是阿斯利康全球四个研发中心之一(另三个中心分别位于英国剑桥、瑞典哥德堡、美国盖瑟斯堡);是国际一流、高产出的创新药研发机构,拥有全球领先的转化医学和新药分子设计与筛选技术平台;在恶性肿瘤、自身免疫性疾病、肾病等重大疾病的新药研究方面积累了丰富经验。